1. Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation
    Aline Brito de Lima et al, 2018, Cancer Microenvironment CrossRef
  2. Aberrant Expression of Extracellular Signal-Regulated Kinase and 15-Hydroxyprostaglandin Dehydrogenase Indicates Radiation Resistance and Poor Prognosis for Patients with Clival Chordomas
    Yixuan Zhai et al, 2018, World Neurosurgery CrossRef
  3. null
    Philip Hochendoner et al, 2018 CrossRef
  4. CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
    Shuai Lu et al, 2018, Cell Death Dis CrossRef
  5. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication
    Liuqi Yang et al, 2018, Experimental Cell Research CrossRef
  6. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
    Seema C. Parte et al, 2018, J Ovarian Res CrossRef
  7. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling
    Shule Xie et al, 2018, Molecular Therapy CrossRef
  8. Ovarian cancer stem cells and their role in drug resistance
    Zalitha Pieterse et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  9. Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
    Rüdiger Klapdor et al, 2019, IJMS CrossRef
  10. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients
    Beáta Soltész et al, 2019, Journal of Biotechnology CrossRef
  11. Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
    Florian Reinhardt et al, 2019, Cancers CrossRef
  12. Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
    Xingyue Zong et al, 2019, Cancers CrossRef
  13. Presence and role of stem cells in ovarian cancer
    Natasa Kenda Suster et al, 2019, WJSC CrossRef
  14. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling
    Yanyan Jia et al, 2019, Life Sciences CrossRef
  15. The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
    null Roberts et al, 2019, Cancers CrossRef
  16. Molecular Mechanisms Underlying the Functions of Cellular Markers Associated with the Phenotype of Cancer Stem Cells
    Eduardo Alvarado-Ortiz et al, 2019, CSCR CrossRef
  17. Strategies for Delivery of siRNAs to Ovarian Cancer Cells
    Rossella Farra et al, 2019, Pharmaceutics CrossRef
  18. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
    Zhenru Xu et al, 2020, Appl Microbiol Biotechnol CrossRef
  19. Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
    E. V. Kaigorodova et al, 2020, Bûll. sib. med. CrossRef
  20. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
    Manuel Abreu et al, 2020, Cells CrossRef
  21. Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
    Kyung Un Choi et al, 2020, J Ovarian Res CrossRef
  22. MicroRNA-132 modifies angiogenesis in patients with ischemic cerebrovascular disease by suppressing the NF‑κB and VEGF pathway
    Fengli Che et al, 2017, Mol Med Report CrossRef
  23. CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer
    Kenji Takashima et al, 2020, Int J Oncol CrossRef
  24. Effectiveness of intraperitoneal chemotherapy for t4 colon cancer
    Yu.A. Shelygin et al, 2020, Khir. Z. im. N.I. Pirogova CrossRef
  25. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.
    Hiromi Konishi et al, 2020, Cancer Biol Ther CrossRef
  26. Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
    Sivasundaram Karnan et al, 2020, Cell Death Discov. CrossRef
  27. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer
    Lin Zhao et al, 2020 CrossRef
  28. The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
    Katrin Kleinmanns et al, 2020, JPM CrossRef
  29. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
    Yang-Hong Ni et al, 2020, CGT CrossRef
  30. CD24 gene inhibition and TIMP-4 gene upregulation by Imperata cylindrica’s root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT
    Paul Nayim et al, 2021, Journal of Ethnopharmacology CrossRef
  31. Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
    Wookyeom Yang et al, 2021, IJMS CrossRef
  32. Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers
    Yizuo Song et al, 2021, Seminars in Cancer Biology CrossRef
  33. CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
    Faroogh Marofi et al, 2021, Front. Oncol. CrossRef
  34. The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas
    Margaretha A. Skowron et al, 2021, Mol Oncol CrossRef
  35. null
    Sarama Saha et al, 2021 CrossRef
  36. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
    Jacek R Wilczyński et al, 2022, IJMS CrossRef
  37. CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
    Katrin Kleinmanns et al, 2020, EBioMedicine CrossRef